Blood panels
Quest and LabCorp draws at wholesale; you set retail and keep the margin.
Programs
Branded blood panels plus a genetic pathway report give your members a clear current-state picture and a long-term roadmap. Results inform the licensed provider.
Members order panels and the genetic report through your app, in your brand.
Quest and LabCorp handle blood draws; the DNA test is a simple one-time collection.
Results inform a licensed provider, who owns any interpretation, evaluation, and prescribing.
Labs and diagnostics are the engine of a modern branded health business: bloodwork shows the current state, and a genetic pathway report adds a long-term roadmap, together making every other program more relevant. Wellstaq supplies both under your brand, with results informing an independent, board-certified network licensed in all 50 states that owns all interpretation and clinical decisions. You set retail on panels and the genetic report and keep that margin; the platform is a flat $2,000/mo, wholesale pass-through, zero percent of your sales.
14 pathways in the genetic report
Quest and LabCorp draws at wholesale; you set retail and keep the margin.
A one-time report mapping variants to pathways as a roadmap; you set retail and keep the margin.
Blood and DNA combined in your branded app to inform provider review.
Results processed through Quest, LabCorp, and CLIA-certified partner labs.
Licensed clinicians in all 50 states owning all interpretation and clinical decisions.
Quest + LabCorp
national lab coverage
A nationwide draw network and CLIA-certified processing mean your members can get tested almost anywhere, with the data feeding directly into provider-owned review.
How the economics work
$2,000/mo flat platform fee — the only cut we take. Blood labs, telehealth and supplements pass through at true wholesale cost; you set retail and keep the margin. Wellstaq takes 0% of your sales.
No. It is an educational, wellness roadmap that maps variants to pathways for discussion with a provider. It does not diagnose, prescribe, or determine which products anyone should use.
A licensed provider in the independent network owns all interpretation and any clinical decision. The data informs them; it does not replace them.
A flat $2,000/mo, wholesale pass-through, and 0% of your sales. Get on the list before spots open.
Wellstaq provides technology and brand infrastructure. All clinical decisions, evaluations and prescribing are made by an independent, board-certified provider network licensed in all 50 states. Wellstaq and its partners make no diagnosis, treatment, efficacy or outcome claims; nothing here is medical advice.